vs

Side-by-side financial comparison of Evolus, Inc. (EOLS) and Telesat Corp (TSAT). Click either name above to swap in a different company.

Telesat Corp is the larger business by last-quarter revenue ($73.8M vs $73.1M, roughly 1.0× Evolus, Inc.). Evolus, Inc. runs the higher net margin — -14.6% vs -119.8%, a 105.2% gap on every dollar of revenue. Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (4.6% CAGR vs -64.0%).

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

Telesat, formerly Telesat Canada, is a Canadian satellite communications company founded on May 2, 1969. The company is headquartered in Ottawa.

EOLS vs TSAT — Head-to-Head

Bigger by revenue
TSAT
TSAT
1.0× larger
TSAT
$73.8M
$73.1M
EOLS
Higher net margin
EOLS
EOLS
105.2% more per $
EOLS
-14.6%
-119.8%
TSAT
Faster 2-yr revenue CAGR
EOLS
EOLS
Annualised
EOLS
4.6%
-64.0%
TSAT

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
EOLS
EOLS
TSAT
TSAT
Revenue
$73.1M
$73.8M
Net Profit
$-10.7M
$-88.4M
Gross Margin
66.9%
95.3%
Operating Margin
23.8%
5.9%
Net Margin
-14.6%
-119.8%
Revenue YoY
6.7%
Net Profit YoY
EPS (diluted)
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EOLS
EOLS
TSAT
TSAT
Q1 26
$73.1M
Q4 25
$90.3M
Q3 25
$69.0M
$73.8M
Q2 25
$69.4M
$77.5M
Q1 25
$68.5M
$152.2M
Q4 24
$78.9M
Q3 24
$61.1M
Q2 24
$66.9M
$363.2M
Net Profit
EOLS
EOLS
TSAT
TSAT
Q1 26
$-10.7M
Q4 25
$130.0K
Q3 25
$-15.7M
$-88.4M
Q2 25
$-17.1M
$55.1M
Q1 25
$-18.9M
$-52.3M
Q4 24
$-6.8M
Q3 24
$-19.2M
Q2 24
$-11.3M
$547.4M
Gross Margin
EOLS
EOLS
TSAT
TSAT
Q1 26
66.9%
Q4 25
65.7%
Q3 25
66.5%
95.3%
Q2 25
65.3%
95.9%
Q1 25
68.1%
Q4 24
66.7%
Q3 24
68.9%
Q2 24
70.3%
Operating Margin
EOLS
EOLS
TSAT
TSAT
Q1 26
23.8%
Q4 25
4.7%
Q3 25
-16.7%
5.9%
Q2 25
-14.7%
16.8%
Q1 25
-22.1%
Q4 24
-2.9%
Q3 24
-25.3%
Q2 24
-11.5%
Net Margin
EOLS
EOLS
TSAT
TSAT
Q1 26
-14.6%
Q4 25
0.1%
Q3 25
-22.8%
-119.8%
Q2 25
-24.7%
71.2%
Q1 25
-27.6%
-34.4%
Q4 24
-8.6%
Q3 24
-31.4%
Q2 24
-17.0%
150.7%
EPS (diluted)
EOLS
EOLS
TSAT
TSAT
Q1 26
$-0.16
Q4 25
$0.01
Q3 25
$-0.24
Q2 25
$-0.27
Q1 25
$-0.30
Q4 24
$-0.11
Q3 24
$-0.30
Q2 24
$-0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EOLS
EOLS
TSAT
TSAT
Cash + ST InvestmentsLiquidity on hand
$49.8M
$352.3M
Total DebtLower is stronger
$156.4M
Stockholders' EquityBook value
$1.6B
Total Assets
$220.6M
$5.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EOLS
EOLS
TSAT
TSAT
Q1 26
$49.8M
Q4 25
$53.8M
Q3 25
$43.5M
$352.3M
Q2 25
$61.7M
$399.6M
Q1 25
$67.9M
$552.1M
Q4 24
$87.0M
Q3 24
$85.0M
Q2 24
$93.7M
$1.7B
Total Debt
EOLS
EOLS
TSAT
TSAT
Q1 26
$156.4M
Q4 25
$146.1M
Q3 25
Q2 25
Q1 25
$121.8M
Q4 24
$121.5M
Q3 24
$121.2M
Q2 24
$120.9M
Stockholders' Equity
EOLS
EOLS
TSAT
TSAT
Q1 26
Q4 25
$-23.1M
Q3 25
$-28.8M
$1.6B
Q2 25
$-18.7M
$1.7B
Q1 25
$-6.6M
$2.5B
Q4 24
$5.5M
Q3 24
$5.9M
Q2 24
$19.3M
$2.4B
Total Assets
EOLS
EOLS
TSAT
TSAT
Q1 26
$220.6M
Q4 25
$225.9M
Q3 25
$219.0M
$5.1B
Q2 25
$228.8M
$4.9B
Q1 25
$213.4M
$6.9B
Q4 24
$232.6M
Q3 24
$229.6M
Q2 24
$233.8M
$6.3B
Debt / Equity
EOLS
EOLS
TSAT
TSAT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
22.00×
Q3 24
20.58×
Q2 24
6.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EOLS
EOLS

Product revenue, net$72.7M99%
Service revenue$390.0K1%

TSAT
TSAT

Segment breakdown not available.

Related Comparisons